These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1372324)

  • 1. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum.
    Mygland A; Tysnes OB; Aarli JA; Flood PR; Gilhus NE
    J Neuroimmunol; 1992 Mar; 37(1-2):1-7. PubMed ID: 1372324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.
    Mygland A; Tysnes OB; Matre R; Aarli JA; Gilhus NE
    Autoimmunity; 1994; 17(4):327-31. PubMed ID: 7948615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
    Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
    J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Ann N Y Acad Sci; 1998 May; 841():530-3. PubMed ID: 9668288
    [No Abstract]   [Full Text] [Related]  

  • 8. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart muscle antibodies in myasthenia gravis.
    Mygland A; Aarli JA; Hofstad H; Gilhus NE
    Autoimmunity; 1991; 10(4):263-7. PubMed ID: 1772962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin.
    Aarli JA; Stefansson K; Marton LS; Wollmann RL
    Clin Exp Immunol; 1990 Nov; 82(2):284-8. PubMed ID: 2242609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
    Chen XJ; Qiao J; Xiao BG; Lu CZ
    J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum anti-titin antibody in patients with myasthenia gravis].
    Li YF; Zhang JB; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
    Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
    Suzuki S
    Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination.
    Aarli JA; Lefvert AK; Tönder O
    J Neuroimmunol; 1981 Dec; 1(4):421-7. PubMed ID: 7346525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodies.
    Gilhus NE; Aarli JA; Matre R
    Neurology; 1984 Feb; 34(2):246-9. PubMed ID: 6363971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity against the ryanodine receptor in myasthenia gravis.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Acta Physiol Scand; 2001 Mar; 171(3):379-84. PubMed ID: 11412151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?
    Aarli JA; Gilhus NE; Hofstad H
    Acta Neurol Scand; 1987 Jul; 76(1):55-7. PubMed ID: 3630645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathological basis of thymoma-associated myasthenia gravis.
    Müller-Hermelink HK; Marx A; Geuder K; Kirchner T
    Ann N Y Acad Sci; 1993 Jun; 681():56-65. PubMed ID: 7689313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.